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Summary The properties of rosettes formed between the Hodgkin's cell lines, L428 and L591, and allogeneic
peripheral blood mononuclear cell populations have been investigated. Immunocytochemical analysis showed
that the majority of adherent cells were T-cells of both the CD4 and CD8 subsets. Only relatively few B-cells
and monocytes were seen to adhere. However, when peripheral blood mononuclear cell populations were
fractionated, it was found that monocytes were as good as T-cells at forming rosettes with both L428 and
L591, though B-cells were shown to be poor at forming such associations. Treatment of both L428 and L591
with neuraminidase resulted in a significant reduction (P<0.01) in the mean number of adherent lymphocytes
and in the numbers of Hodgkin's tumour cells which formed rosettes. Smaller, less significant effects were
observed for Cytochalasin B and trypsin. EDTA (10-2M) at pH7.2 had no significant effect on rosetting for
L428 or L591. Adherence of allogeneic lymphocytes to L428 or L591 was pH dependent but did not appear
to correlate with cell surface charge. Treatment of L428 cells with Fab fragments prepared from the IgG
fraction of a hyperimmune rabbit anti-L428 antiserum, significantly (P<0.05) inhibited the adherence of
allogeneic lymphocytes, but only when used at high concentration. The binding requirements of the
Hodgkin's cell lines with allogeneic peripheral blood lymphocytes, as described in this study, appear to be
quite different from those described for freshly isolated Hodgkin's tumour cells with autologous intratumoral
lymphocytes. This suggests that the two phenomena may be unrelated. There would appear to be an absolute
requirement for cell surface sialic acid for allogeneic lymphocyte attachment to the HD cell lines. This might
suggest that the receptor-ligand system involved contains sialic acid as an integral part of the cell surface
receptor structure involved in recognition of the appropriate ligand.
The adherence of T-lymphocytes to Hodgkin's mononuclear
(HM) and Reed-Sternberg (RS) cells has been described
both in fresh imprints of Hodgkin's disease tissue (Abdulaziz
et al., 1984; Poppema et al., 1982) and for single cell
suspensions prepared from involved lymph nodes and spleen
(Sundeen et al., 1987; Stuart et al., 1977; Payne et al., 1980;
Kadin et al., 1974). The significance of this association is
unknown, although limited evidence for a host mediated
cytotoxic attack on the tumour cell population has been
claimed (Archibald & Frenster, 1973; Kay, 1976) but never
substantiated. The survival of Hodgkin cell-lymphocyte
rosettes for up to five weeks in vitro (Payne et al., 1977) and
the observation that T-cells binding to the RS/HM cell are
predominantly of the T helper (CD4+) subset (Morris &
Stuart, 1984) strongly suggests that the interaction is not a
cytotoxic attack on the tumour cell population. It has been
further observed by Payne et al. (1980) that the binding of
T-cells to the RS/HM cell is characteristically quite different
from that observed for T-cell/target cell binding (Lipsky &
Rosenthal, 1973) for T-cell/lymphoblast binding (Jondal et
al., 1975) or for antigen independent T-cell/macrophage
adherence (Henney & Bubbers, 1973). This led Payne et al.
(1980) to conclude that a unique receptor system might be
involved in RS/HM-T-cell interaction. The experimental
confirmation of such a possibility has, however, been
difficult to achieve, primarily because of a lack of suitable
numbers of RS/HM cells, which are difficult to isolate in
sufficient numbers from involved tissues. The introduction of
several independently derived Hodgkin's disease-derived cell
lines in recent years, some of which are capable of forming
rosettes with allogeneic T-cells (Schaadt et al., 1980; Diehl et
al., 1982; Jones et al., 1985), provides a readily available
source of material for the investigation of this cell adhesion
phenomenon. Whether these Hodgkin's-derived cell lines are
representative of the true tumour cell population of HD still
remains to be unequivocally proved and it remains a
possibility that the in vitro rosettes formed by these cell lines
with allogeneic lymphocytes may not be relevant to the in
vivo interaction. None the less, the cell lines provide us with
the only likely alternative for studying this phenomenon in
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detail at the present time and the possibility of raising a
monoclonal antibody against a Hodgkin's cell line surface
adhesion molecule(s) responsible for binding T-cells would
provide a valuable probe for studying this phenomenon
further.
We have undertaken in the present study to investigate the
properties of rosettes formed between the two Hodgkin's
disease-derived cell lines, L428 and L591, and allogeneic
peripheral blood mononuclear cells to establish similarities
and differences between this cell-cell interaction and that
previously described for freshly isolated RS/HM cells with
autologous intratumoral lymphocyte populations.
Materials and methods
Cell lines and peripheral blood mononuclear cells
The Hodgkin's disease derived cell lines, L428 and L591,
both derived from different patients with the nodular
sclerosing (NS) subtype of HD (Schaadt et al., 1980; Diehl et
al., 1982), have been maintained in this laboratory for three
years to RPMI 1640 medium containing 10% fetal calf
serum, 100IUml-1 benzyl penicillin, 100 ugml-1 strepto-
mycin sulphate and 200mM glutamine (complete RPMI).
The cell line Co developed in this laboratory (Jones et al.,
1985) was also maintained in complete RPMI. Originally this
Hodgkin's-drived cell line formed rosettes with allogeneic
lymphocytes but has lost this ability following successive
passages. All cell lines were maintained at 37°C in a
humidified atmosphere of 5% CO2 and cultures were split at
twice-weekly intervals to maintain cells in the logarithmic
phase of growth.
Normal peripheral blood mononuclear cells were obtained
from whole blood from normal volunteer subjects following
centrifugation over Ficoll-Hypaque. A second centrifugation
step over isotonic Percoll (Pharmacia, Milton Keynes, UK;
specific gravity 1.06) yielded two fractions enriched for
lymphocytes (pellet) or monocytes (top buoyant fraction).
The lymphocyte-enriched fraction was used for all the
rosetting assays described below, with the exception of
studies aimed at determining the immunophenotypes of
mononuclear cells forming associations with the Hodgkin's
lines, where the mononuclear cell fraction obtained from the
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Ficoll-Hypaque step were used directly as the rosetting
population.
The peripheral blood lymphocyte fraction was enriched for
B-cells (CD37+), T-cells (CD3+), T-helper cells (CD4+) and
T-supressor cells (CD8 +) by negative selection using a
panning technique. Briefly, Petri dishes were coated with
affinity purified sheep anti-mouse immunoglobulins antibody
(20pgml-1) in bicarbonate coating buffer (pH9.5) by in-
cubating 10ml of antibody in each Petri dish for 40min at
room temperature. Petri dishes were washed three times with
phosphate buffered saline (PBS) pH7.2 containing 1% fetal
calf serum and set aside at 4°C. Peripheral blood lympho-
cytes were incubated for 30min with the appropriate mono-
clonal antibodies at 4°C in the presence of 0.01% sodium
azide, washed three times in PBS, resuspended in PBS
containing 5% FCS and the antibody coated cells distributed
over the sheep anti-mouse immunoglobulins coated Petri
dish. Petri dishes were centrifuged at lOOg for 5min at 4°C
on a swing out rotor and incubated at 4°C for 30min. Non-
adherent cells were decanted from the Petri dish and the
procedure was repeated once more. By using appropriate
monoclonal antibodies, as shown in Table III, it was
possible to enrich the non-adherent and thus negatively
selected population of peripheral blood lymphocytes for B-
cells (CD37), T-cells (CD3+) and T-cells of the T-helper
(CD4 +) and T-suppressor (CD8 +) subsets. The degree of
enrichment achieved for these lymphocyte populations is
shown in Table III.
Rosette assay
Lymphocytes and Hodgkin's cell lines were washed three
times by centrifugation in serum-free RPMI 1640. Cells were
adjusted to 1 x 106 ml-1 and 2 x 104 tumour cells mixed with
2 x 105 lymphocytes (or with an equivalent number of cells
of the rosetting population under study), pelleted by centri-
fugation at lOOg for 2min and incubated at room
temperature for one hour. Following incubation, 2ml of
serum-free RPMI medium was gently added and cells were
resuspended by very gently blowing a stream of medium
across the pellet with a Pasteur pipette. Cytocentrifuge
preparatations of resuspended cells/rosettes were made in a
Shandon cytocentrifuge and stained by the Diffquik*
method (Paramount Reagents Ltd, Merseyside, UK) or by
the immunoperoxidase ABComplex method (Dako Ltd,
High Wycombe, UK) after staining with specific monoclonal
antibodies. Four cytocentrifuge slides were prepared for each
treatment and each treatment (and controls) was repeated in
duplicate on different occasions. Each treatment therefore
yielded eight slides. Ten tumour cells were selected at
random from each slide and the number of adherent
peripheral blood mononuclear cells counted. This posed no
difficulty as it is easy to distinguish on morphological
grounds alone between the Hodgkin's cell line and peripheral
blood cell populations. The number of adherent cells was
therefore evaluated for 80 separate Hodgkin's cells for each
individual treatment and the mean number of adherent cells
and standard deviations calculated for each. The statistical
significance of differences between the control and treatment
groups was evaluated using Student's t-test. The mean
number of Hodgkin cell adherent blood mononuclear cells of
a given immunophenotype was evalutated in exactly the
same way except that only adherent cells with a defined
immunophenotype, as shown immunocytochemically, were
counted. The percentage of L428 and L591 cells which
formed rosettes was also estimated by counting the total
number of tumour cells in 10 separate microscope fields and
the number of tumour cells of this total which had one or
more adherent mononuclear cells. The percentage was
calculated from the formula:
% rosetting Hodgkin cells=
Number rosetting Hodgkin cells
Total number of Hodgkin cells
Rosette inhibition
The effects of the various chemical agents, enzymes and
antibodies on the ability of L428 and L591 to bind
allogeneic peripheral blood lymphocytes were investigated.
Following treatment of the Hodgkin's cell line with each
agent, under conditions prescribed in Table I, the rosetting
assay was carried out and results scored exactly as described
previously.
Immunocytochemical staining of cytocentrifuge preparations
Cytocentrifuge preparations of L428 and L591 rosettes were
air dried and fixed in anhydrous acetone, and the
appropriate first antibody was applied. The ABComplex
method (Dako Ltd, High Wycombe, UK), employing a
biotinylated anti-mouse or anti-rabbit immunoglobulins
antibody and a diaminobenzidine/H202 based substrate, was
used to reveal binding of specifically bound first antibody.
Preparation of Fab from rabbit anti-L428 antiserum
Two Half Lop rabbits (Foxfield Rabbits, Essex, UK),
weighing 3-4kg, were immunised with 1 x 107 L428 cells in
Freund's complete adjuvant (FCA) by injection into four
subcutaneous (s.c.) sites over the flank. Rabbits were
boosted 21 days later with the same number of L428 cells,
also in FCA, by injection into four different s.c. sites and
one intramuscular site. Animals were boosted 14 and 28 days
later by injection of 5 x 106 L428 cells intravenously (i.v.)
and bled seven days after the final boost. Blood was allowed
to clot at room temperature for 4-6 hours and serum was
harvested by centrifugation.
IgG was prepared from the whole antiserum by
ammonium sulphate precipitation and ion exchange
Table I Chemical agents, enzymes and antiserum used in the study of inhibition of rosette formation
of the Hodgkin cell lines L428 and L591 with allogeneic peripheral blood lymphocytes
Agent Concentration Assay conditions
EDTAu (ph 7.2 and 4.5) 10-2 M Rosette assay carried out with these agents
Sodium azidea 102*M included in medium
Monosaccharide sugarsb 10 2M J
Trypsina 0.25%0 L428/L591 cells treated with appropriate
(pH 6.8) enzyme/antibody for 1 h at 37°C (4°C for Fab),
Neuraminidasea 200Uml 1 cells washed three times in medium and used
(pH 5.6) J directly in rosette assay
Anti-L428 Fab 1 mgml 1(neat)
Tunicamycinb 1 jugml- 1 L428/L591 cells cultured for 24h at 37°C in
Colchicineb 10-4M . medium containing appropriate agent, washed
Phorbol myristate acetateb 1.8x 10-8M three times in medium and used directly in
Cytochalasin Bb lO1gml-, rosette assay
Suppliers: aBDH, Poole, Dorset, UK; bSigma Chemical Co, Poole, UK.HODGKIN'S CELL LINE ROSETTES 167
chromatography on DEAE cellulose. The IgC con-
centration was adjusted to 17mgml-1 in a total volume of
3 ml 0.1 M sodium phosphate (pH 7.0) containing 0.01 M
cysteine and 2mM EDTA. One milligram of Papain (Sigma
Chemical Co., Poole, UK) was dissolved in 100,l 0.1 M
sodium phosphate buffer (pH7.0) and 50Ml was added to the
IgG in 3ml of phosphate buffer and incubated for 16h at
37°C with very gentle stirring. The resulting digest was
dialysed against water and then three changes of 500ml
0.01 M sodium acetate (pH 5.5). The dialysed digest was
applied to a carboxyymethyl cellulose chromatography
column equilibrated with 0.01 M sodium acetate buffer
(pH 5.5) and the components bound to the column were
eluted with a linear 0.01-1 M gradient of sodium acetate
buffer (pH5.5). Fab containing fractions were collected in
the first and second order peaks emerging from the column.
Fab fractions were pooled, concentrated, dialysed against
PBS (pH 7.2) and adjusted to a concentration of 1 mgml -.
The purity of the Fab preparation was confirmed by sodium
dodecyl polyacrylamide gel electrophoresis (SDS PAGE)
under non-reducing conditions (Laemmli, 1970) which
revealed a single 50kd band following coomasie blue
staining of gels. The Fab fragment was also shown to retain
its binding to cytocentrifuge preparations of L428 cells.
Measurement of cell electrophoretic mobilities
Electrophoretic mobilities of cells were made at 25°C in PBS
(pH 7.2) containing 5% (w/v) sucrose on a Rank Brothers
Mark I microelectrophoresis apparatus with a cylindrical
sample cell. Care was taken to focus on the stationery layer
and the time taken for a cell to traverse 25pm at 60V was
measured.
The electrophoretic mobility, u-, of a given cell was
calculated from the formula:
_ ml/s
U=V/rn2
where m1 is the distance travelled by the cell in metres
(2.5 x 10-I m), s is the time in seconds for the cell to traverse
25pm, v is the voltage (60V) and m2 is the distance in
metres between cathode and anode (0.165m).
The zeta potential, (, the potential of the cell at the
hydrodynamic plane of shear, was calculated from the
measured value of the electrophoretic mobility, i.e. using the
Helmholtz-Smoluchowski equation:
4 =U?1/8,Eo
Where il is the viscosity of a 5% sucrose solution at 25°C, es
is the permeability of water and g0 is the relative
permeability of free space. Previous studies have concluded
that 4 corresponds to the potential difference 2A from the
surface of the cell membrane (Rooney & Lee, 1983;
Eisenberg et al., 1979; Lee et al., 1982).
Results
Morphology of rosettes
Figure 1 shows some of the typical appearances of rosettes
formed by associations of L428 and L591 with peripheral
blood mononuclear cells. Most commonly, rosettes
comprised a single, complete or incomplete mantle of
lymphoid cells surrounding the Hodgkin's cell, shown for
L428 in Figure la and L591 in Figure lb. Less commonly,
though more frequently for L428 than L591, multiple layers
of attached lymphoid cells were encountered, occasionally up
to three cells deep in points (Figure Ic). Filamentous
protrusions were frequently seen to emerge from the L428
cell surface and, where this occurred, the adherent lymphoid
population in the vicinity appeared to be entrapped by, or
adherent to, these filaments (Figure ld).
a b
d
Figure 1 Morphological appearances of rosettes formed
between the Hodgkin's-derived cell lines, L428 and L591, and
allogeneic peripheral blood lymphocytes. Typical rosettes formed
by (a) L428 and (b) L591; (c) formation of multiple layers of
lymphocytes adherent to an L428 cell; (d) filamentous
protrusions emerging from the surface of a rosetting L428 cell.
x 250 a and c; x 350 b and d. Diffquik stain.
Rosette kinetics
Figure 2 shows the curves obtained for the percentages of
L428 and L591 cells forming rosettes, and the mean number
of adherent lymphocytes per Hodgkin cell, at Hodgkin
tumour cell to lymphocyte ratios of 1:1, 1:10, 1:100, 1:200
and 1:500. Clearly there are differences in curve shape
obtained for L428 and L591. L428 gives a sigmoidal plot
with a sharp increase in the number of adherent lymphocytes
at ratios between 1:10 and 1:100, thereafter plateauing out.
The curve obtained for L591 was a simple parabola, with the
steepest part of the curve occurring between ratios of 1:1 and
1:100, again plateauing out thereafter. It is also apparent
that more lymphocytes adhered to L428 than to L591,
although the numbers doing so were approximately equal for
both L428 and L591 up to a ratio of 1:10, where mean
values of 3.55 and 3.80 lymphocytes per Hodgkin cell were
observed for L428 and L591, respectively. Above this ratio
the number of L591 adherent lymphocytes plateaued out,
while the number of L428 adherent lymphocytes continued
to increase, reaching a mean value of 9.10 lymphocytes per
L428 cell at a ration of 1:100 and 9.74 at 1:200. When the
percentage of Hodgkin cells forming rosettes was plotted
against the Hodgkin cell to lymphocyte ratio, a similar
picture emerged for both cell lines (Figure 2). At a ratio of
1:1 only 16% of L428 and 2% of L591 cells were seen to
form rosettes, contrasting with 79% and 61% at a ratio of
1:10 for L428 and L591 respectively. There was no further
increase in the number of L428 cells forming rosettes at
ratios beyond 1:10, though there was an increase for L591
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Figure 2 The mean number of rosetting lymphocytes per L428
or L591 Hodgkin tumour cell 0 and the percentage of Hodgkin
cells forming rosettes 0 with increasing numbers of lymphocytes
added to 104 Hodgkin's cells.
which eventually plateaued out at 1:100 with 71% of cells
forming rosettes.
Effects of temperature on rosette formation
The effects of temperature in the range from 4 to 37°C on
lymphocyte adherence to the two Hodgkin's cell lines are
shown in Figure 3a. Rosettes formed equally well at all three
temperatures for both cell lines.
Effects ofpH on rosette formation
Figure 4 shows the effects of pH in the range from 2 to 10
on lymphocyte attachment to L428 and L591. Clearly, the
optimal pH range lies between 5 and 8 for both cell lines,
with both the mean number of rosetting lymphocytes and
the percentage of Hodgkin cells forming rosettes falling
off sharply at either side of this range. At pH 2 no rosettes
were observed, with the tumour cells showing a markedly
shrunken and damaged appearance.
Immunophenotyping of rosetting cell populations
Table II details the immunophenotypes of the allogeneic
peripheral blood mononuclear cell populations adherent to
L428 and L591. The vast majority of the rosetting
population were T-cells, evidenced by the expression of CD3
antigen by 93% and 91% of the L428 and L591 adherent
cell population respectively. Of these adherent T-cells, 36%
and 27%, for L428 and L591 respectively, were of the T-
suppressor/cytotoxic (CD8 +) subset and 33% and 28%,
respectively, of the T-helper/inducer (CD4+) subset. Only a
small minority of the peripheral blood cells adherent to L428
and L591 were B-cells or monocytes as shown by the
expression of CD37 or CD14 antigens (Table II).
Adherence offractionated mononuclear cell populations to
Hodgkin's cell lines
Table III details the degree of enrichment obtained for
CD3 +, CD4+ and CD8+ T-cells and CD37+ B-cells
L591
4°C 22°C 37°C 4°C 22°C 37°C
b
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Figure 3 Histograms showing the effects of (a) temperature (4-
37°C) and (b) 1O-2M EDTA at pH 7.2 amd 4.5, on the mean
number of adherent lymphocytes [1 and the percentage of
rosettes forming Hodgkin's cells N. Bars represent one standard
deviation.
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Figure 4 The effects of pH (2-10) on the mean number of
lymphocytes forming rosettes with L428 or L591 * and on the
percentage of Hodgkin tumour cells forming rosettes 0.
obtained following negative selection by panning normal
peripheral blood lymphocytes with the various described
monoclonal antibodies. Enrichment for T-cells was very
effective, 82% purity being achieved with only 6%
contaminating B-cells and no detectable monocytes. En-
richment for CD4+ cells from the CD3 + enriched
population was also good, with 63% expressing CD4 and
with only 6% contaminating CD8 + cells and 2% CD37+ B-
cells. Enrichment for CD8 + cells from the CD3+ enriched
population was less satisfactory, 59% of the cells expressing
CD8 antigen but with 26% contaminating CD4+ cells and
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Table II Immunophenotypes of peripheral blood mononuclear cell
populations forming rosettes with the Hodgkin cell lines L428 and L591
No. positive rosetting cellsl
total no. rosetting celjs (%)
Mab CD Phenotype L428 L591
UCHTla CD3 T-cell 119/139 (93%) 49/54 (91%)
OKT8b CD8 T.-cell 52/146 (36%) 17/64 (27%)
OKT4b CD4 Th-cell 48/147 (33%) 19/68 (28%)
WR17C CD37 B-cell 6/114 (5%) 2/81 (2%)
UCHM1d CD14 M0 3/125 (2%) 7/79 (9%)
aBeverley & Callard (1981); bEngleman et al. (1981); cMoore et al. (1987);
dHogg, unpublished.
Table III Expression of T-cell, B-cell and monocyte markers by normal peripheral blood
mononuclear cells enriched for T-cells, Tb-cells, T,-cells, B-cells and monocytes by
negative selection on panning
% enriched cell population expressing
Enriched UCHTJ OKT4 OKT8 UCHMI WR17
population (CD3) (CD4) (CD8) (CD14) (CD37)
Unfractionated
PB mononuclear cells 36 15 21 23 12
T-cella
(CD3+) 82 34 19 0 6
Th-cellb
(CD4+) 78 63 6 0 2
Ts-cellc
(CD8+) 91 26 59 1 8
B-cell'
(CD37+) 28 16 5 0 64
moe
(CD14+) 5 0 0 0 93
Populations were negatively selected by depletion of cell populations with the following
monoclonal antibodies: 'UCHMI (CD14), WR17 (CD37) T-cell enriched; bOKT8 (CD8)
depletion of T-cell enriched population; COKT4 (CD4) depletion of T-cell enriched
population; dUCHTI (CD3), UCHM1 (CD14) enriched for B-cells; 'Enriched monocytes
obtained from Percoll (s.g. 1.06) top fraction.
8% CD37+ B-cells. Of the B-cell enriched population, 64%
expressed the pan B-cell marker CD37 but 28% of the cells
were contaminating CD3+ T-cells. The highest degree of
enrichment was obtained for monocytes, comprising 93%
cells expressing CD14 antigen with only 5% contaminating
T-cells.
The results obtained following rosetting of the fractionated
lymphocyte subpopulations and monocytes with L428 and
L591 at a ratio of 1:10 are shown in Figure 5. Clearly
revealed here is the observation that all T-cells (CD3 +,
CD4+ and CD8 +) and monocytes (CD14+) areequallygood
at forming rosettes with both Hodgkin's cell lines. Immuno-
phenotypic analysis of the adherent T-cell populations
revealed that the majority of the adherent cells were of the
relevant enriched cell population. B-cells (CD37+) were poor
at forming adhesive associations with either of the Hodgkin's
cell lines and only low percentages of the CD37 enriched
rosetting populations were actually B-cells, the majority
being comprised of contaminating T-cells.
Effects of various agents on rosetting
Figure 6 details the effects of treating the Hodgkin's cell
lines L428 and L591 with various chemical agents/enzymes
on their ability to form rosettes with allogeneic lymphocytes
at a ratio of 1:10. Treatment of L428 and L591 with
neuraminidase resulted in a highly significant (P<0.01)
reduction in the mean number of lymphocytes adherent to
both cell lines. There was also a reduction in the observed
percentage of tumour cells forming rosettes for both cell
lines. A smaller, though only marginally significant (P<0.05)
reduction in the mean number of adherent lymphocytes was
noted with Cytochalasin B for L428 only. Removal of
trypsin-sensitive membrane surface proteins from L428 and
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indicate one standard deviation.
L591 did not result in a significant reduction in the number
of adherent lymphocytes, though there was a moderate
reduction in the percentage of Hodgkin's cells forming
rosettes, which fell to 65% and 45%, respectively (Figure 6).
Treatment with EDTA (pH 7.2), colchicine, sodium azide,
tunicamycin or phorbol myristate acetate (PMA) had no
significant effect on rosetting for either L428 or L591.
Effects of EDTA on rosetting
The effects of EDTA (10-2 M) on rosetting were further
investigated and the results are shown in Figure 3b. In these
experiments EDTA was added to Hanks balanced salts
solution (HBSS) yielding a solution of pH4.5. The pH of a
portion of the HBSS was adjusted to pH 7.2 by the dropwise
addition of 1 M TRIS and rosetting carried out in HBSS at
both pH values. Controls consisted of rosettes formed in
non-supplemented HBSS (pH 7.2). It is clear from Figure 3b
that EDTA at pH 7.2 had only a marginal effect on
rosetting, with the mean number of adherent lymphocytes
falling from 6.04 to 5.00 for L428 and from 3.97 to 3.64 for
L591. When rosetting was carried out in HBSS at pH 4.5,
there was a marked, though non-significant, reduction in the
mean number of adherent lymphocytes from 6.04 to 3.60 for
L428 and a significant reduction for L591 (P<0.05) from
3.97 to 1.74. There was also a marked reduction in the
percentage of tumour cells forming rosettes in the presence
of EDTA at pHn4.5 from 91% to 42% for L428 and from
71% to 51% for L591. This was not observed for EDTA
used at pH7.2.
The effects of monosaccharide sugars
The effects of various monosaccharide sugars (100mM) on
rosette formation by L428 and L591 are shown in Table IV.
None of these sugars had any significant effect on rosetting
for either cell line.
Cell surface charge (zeta potential)
Figure 7 shows the scattergraph plots of the measured zeta
potentials obtained for the two rosette-forming Hodgkin's
lines L428 and L591 and for the non-rosetting Hodgkin's
line Co, before and following treatment with neuraminidase.
Also shown are zeta potentials obtained for normal
peripheral blood B-cells (CD37+), T-cells (CD3+) and
monocytes (CD14+). All of the cell types studied migrated
towards the cathode, indicating that all cells were negatively
charged. Of the Hodgkin's lines, L428 possessed the least
surface charge (mean 8.113mV) which, following neuramini-
dase treatment, fell significantly (P<0.001) to 2.391 with
over half the cells showing a total loss of surface charge.
L591 and Co possessed similar mean charges of 12.09 and
12.79, respectively, these values falling to 8.54mV for L591
and 10.87mV for Co following neuraminidase treatment.
The mean zeta potential values for the variety of peripheral
blood mononuclear cells studied were all very similar, being
12.16, 12.35 and 12.57mV for T-cells (CD3+), B-cells
(CD37+) and monocytes, respectively. A point worthy of
remark here concerns the range of zeta potentials observed
for T-cells, which was considerably narrower than observed
for either B-cells or monocytes.
Effects of anti-L428 Fab on lymphocyte adherence
Table V shows the results obtained when the Hodgkin's cell
line L428 was treated with univalent Fab fragments prepared
from the IgG fraction of a rabbit anti-L428 antiserum. It
was demonstrated immunocytochemically that both the
native antiserum and Fab fragments prepared from this
specifically bound to L428 cells on cytocentrifuge
preparations. Preincubation of L428 cells for 30min at 4°C
with neat anti-L428 Fab produced a significant (P<0.05)
reduction in the number of adherent lymphocytes from a
mean of 4.83 in the control down to 2.50 in the treated cells
and a small reduction in the percentage of L428 cells
forming rosettes, from 66% to 57%.
Discussion
These studies show clearly that the major requirements for
the attachment of allogeneic peripheral blood lymphocytes to
the Hodgkin's cell lines L428 and L591 are the same. This
would probably indicate that the cell adhesion mechanism is
also the same for the two cell lines, though clearly L428 is
capable of binding a greater number of peripheral blood
lymphocytes than L591. This may be accounted for by the
fact that an average L428 cell is considerably larger (20-
80pm) than an average L591 cell (10-20,um) and is
Table IV Effects of various monosaccharide sugars (100mM) on rosetting by L428 and L591
Mean no. rosetting lymphocytesl % Hodgkin cells
Hodgkin cell±s.d. forming rosettes
L428 L591 L428 L591
Control 5.61+1.73 4.12+2.61 79 62
,B-D-glucose 6.19+2.78 4.64+ 1.83 84 54
D-(+) galactose 5.19+2.84 4.97+2.46 76 69
L-(-) fucose 6.21+1.06 3.81+2.77 79 66
Methyl-D-mannoside 5.50+2.39 4.00+ 1.74 86 66
N-acetyle-D-glucosamine 5.86+ 1.84 4.89+1.17 81 71
N-acetyl neuraminic acid (pH7.2) 6.17+ 1.84 3.06+ 1.19 84 56HODGKIN'S CELL LINE ROSETTES 171
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Figure 7 Scattergraph of measured zeta potentials (mV) for the
two rosetting Hodgkin's cell lines L428 and L591, and the non-
rosetting Hodgkin line. Co, before and after treatment with
neuraminidase. Measured zeta potentials for T-cells, B-cells and
monocytes are also shown. Bars indicate one standard deviation
either side of the calculated mean (x) shown numerically at the
top of each column.
therefore physically capable of binding a larger rosetting
population. Both cell lines were derived from different
patients with the nodular sclerosing (NS) subtype of
Hodgkin's disease (Diehl et al., 1982). On the basis of
immunophenotypic and genotypic evidence L428 would
appear to be derived from an activated pre-B-cell (Falk et
al., 1987) while L591 is positive for Epstein-Barr nuclear
antigen (Diehl et al., 1982), indicating a probable derivation
from an Epstein-Barr virus (EBV) immortalised lymphocyte
from within the Hodgkin's lesion (Weiss et al., 1987) and it
is therefore unlikely to be related to the Hodgkin tumour cell
population. The major binding requirements for allogeneic
peripheral blood lymphocytes to L428 and L591 compared
with those for freshly isolated RS/HM cells with autologous
intratumoral-derived lymphocytes, as reported by Payne et
al. (1980), are shown in Table VI. There are clearly major
differences between the two systems, namely the temperature
independence, lack of requirement for divalent cations and
lack of requirement for trypsin sensitive surface membrane
proteins by the cell line system, all of which are absolute
requirements for the fresh RS/HM cell system (Payne et al.,
1980). This might be immediately seen to indicate that the
adhesion mechanism for the HD cell lines and for freshly
isolated RS/HM cells is different and therefore an unrelated
biological phenomenon. However, before drawing such a
conclusion certain key differences between the cell line and
fresh RS/HM cell system must be taken into consideration.
In the first instance, the cell line rosetting system uses
allogeneic rosetting populations, unlike the fresh tissue
system which is completely autologous, employing rosetting
lymphocytes intrinsic to the tumour. The Hodgkin's tumour-
derived autologous lymphocyte populations may also possess
properties determined by their state of activation, and this
may in turn modify their adherence characteristics. Secondly,
there are important differences between the cell line and
fresh RS/HM cell systems in terms of the way in which the
inhibitory effects of the various agents on rosetting are
studied. To investigate the effects of an agent in Payne's
fresh RS/HM system, existing preformed rosettes in
suspension were exposed to a particular agent, and thus the
Hodgkin's tumour cell and adherent population(s) were
exposed to the agent. This is quite different from the cell line
system in the present study, where the HD cell line alone
was exposed to the agent under study. While it can be
argued that these fundamental differences might account for
the observed requirement differences between the cell line
and fresh tissue cell suspension systems as listed in Table VI,
this seems unlikely in the view of the present authors. The
differences are so fundamental as to suggest that completely
different adhesion mechanisms exist for the two.
It is clear from out studies that divalent cations are not a
requirement for cell line rosetting, an observation which we
have made on numerous separate occasions. Where chelating
Mg2 + and Ca2 + with EDTA did result in a decrease in
rosetting in the present study, this was clearly shown to be a
pH-related effect. These findings contrast sharply with those
of Payne et al. (1980), where divalent cations were an
absolute requirement for rosette formation and maintenance.
Removal of membrane surface sialic acid from both
Hodgkin's cell lines with neuraminidase produced an almost
total abrogation of lymphocyte adherence, again in contrast
to the observations of Payne et al. (1980), who observed that
neuraminidase treatment has no appreciable effect on
rosetting. The obvious conclusion to be drawn here is that
terminal sialic acid residues on cell surface glycoconjugates
expressed by the HD cell lines form an essential element in
lymphocyte adhesion, perhaps constituting part of a receptor
structure. Treatment of L428 or L591 with the N-
glycosylation inhibitory agent tunicamycin did not, however,
Table V Effects of treatment of L428 cells with Fab' prepared from rabbit
anti-L428 hyperimmune antisera upon their rosette forming ability
Mean no. rosetting
lymphocytesl %L428 cells
Titre anti-L428 Fab' L428 cell+s.d. forming rosettes
4.83 +2.192 66%
Neat (I mgml- 1) 2.50+ 1.395a 57%
1:10 5.00+3.427 79%
1:100 4.10+1.523 82%
1:1000 5.00+2.788 73%
ap<0.005.
Table VI Some major requirements for rosette formation between lymphocytes and freshly
isolated Hodgkin tumour cells and Hodgkin's-derived cell lines
Active Divalent Micro Sialic
Temp pH metabolism cations tubules acid
Fresh HD tissue rosettes ? - + + -
(Payne et al. 1980)
Hodgkin cell line rosettes - + - - +(?) +
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inhibit lymphocyte adherence, indicating that glycoproteins
with N-linked carbohydrate are unlikely to be involved. This
however, does not exclude the involvement of O-glycoside
linked glycoproteins, glycolipids or proteoglycans. The
significant inhibition of lymphocyte adherence to L428 by
high concentrations (1 mgml-1) of Fab fragments prepared
from a rabbit anti-L428 antiserum would probably indicate
that this antiserum contains antibodies directed against a
structure(s) involved in adherence. This activity, however,
rapidly declined at levels below 1 mgml-1, suggesting that
only very low levels of specific antibody were present. We
are currently investigating the possibility of using such an
antiserum for identifying the relevant adhesion structure(s)
expressed by the L428 cell.
An alternative possiblity is that adhesion may result from
electrical charge differences between the Hodgkin's cell lines
and lymphocytes, but it is difficult to equate this possibility
with the observations made in the present study. Both L428
and L591 carry net negative electrical charges, as do T-cells,
B-cells and monocytes, and all should therefore predictably
repel each other. It is perhaps worth noting that L428, the
best rosetting cell line, possessed the smallest surface charge
of all cells studied and, moreover, this charge disappeared
completely in over half of the cells studied, following
removal of cell surface sialic acid with neuraminidase, a
treatment which concomitantly abolishes their rosetting
capability. L591 does not rosette as efficiency as L428 and
possesses a mean surface charge comparable with lympho-
cytes and monocytes. These data make it seem unlikely that
Hodgkin cell surface charge is involved in lymphocyte
adherence. The coincidental loss of rosetting capability with
decrease and even total loss of cell surface charge in the case
of L428 following neuraminidase treatment points to an
important involvement of sialic acjd in lymphocyte
adherence. However, it was not possible to inhibit lymphocyte
adherence to either L428 or L591 with sialic acid in solution,
possibly indicating that this monosaccharide sugar comprises
only part of the receptor structure involved in adherence.
One observation favouring electrical charge-mediated
adherence is that of the occasional formation of multiple
layers of lymphocytes sometimes seen to surround L428.
These are probably nQt artefacts of cytocentrifugation, as
similar multilayer formations have been observed by us
following the culturing of L428 and lymphocytes together in
flat bottomed wells. However, when such multilayered
rosettes do occur, they appear to be associated with
filaments emanating from the L428 cell (Figure ld) and in
these instances lymphocytes appear to be entrapped or
adherent to these structures. Similar filaments have been
observed for freshly isolated RS cells by Stuart et al. (1977)
who termed these 'porcupine quills'.
Immunophenotypic analysis demonstrates that
unfractionated peripheral blood cell populations forming
associations with L428 and L591 are predominantly CD3+
T-cells of which there are approximately equal numbers of
adherent CD4+ and CD8+ cells, there being a slight excess
of CD4+ cells for L591. Only very few B-cells (CD37+) or
monocytes (CD14+) were shown to adhere. The ratio of
CD4+ to CD8 + T-cell subsets in peripheral blood is
approximately 65:35 (Reinhertz et al., 1979, 1980), and the
observations that equal numbers ofCD4+ and CD8+ T-cells
from the unfractionated peripheral blood mononuclear cell
fraction adhere to the Hodgkin's cell line indicates that the
CD4+ subset forms associations less efficiently.
B-cell enriched fractions were generally poor at adhering
to both L428 and L591 but peripheral blood monocytes were
found to be at least as good as T-cells. We must therefore
assume that, whatever the mechanism of attachment might
be, T-cells, a proportion of B-cells and all monocytes adhere
to the Hodgkin cell lines through a common mechanism(s).
Morris & Stuart (1984) found that CD4+ T-cells attached
more frequently to RS/HM cells than CD8+ T-cells in fresh
cell suspensions prepared from Hodgkin's involved lymph
nodes. Previous studies have shown that for the majority of
HD cases of all subtypes studied, with the exception of the
lymphocyte depleted subtype, the majority of the T-cell
population in the involved node are of the CD4+ subset
(Dorreen et al., 1982; Poppema et al., 1982; Abdulaziz et al.,
1984) and thus, the apparently more frequent association of
CD4+ T-cells with RS/HM cells may simply reflect the
higher proportion of CD4+ cells available to compete for
attachment.
We feel it likely that lymphocyte/monocyte adherence to
L428 and L591 is mediated by'the same or very similar
mechanisms, but feel it unlikely, despite certain similarities,
that this phenomenon is related to the rosetting reaction
observed between RS/HM cells and T-lymphocytes in
Hodgkin's-involved tissue in situ. Several leucocyte adherence
molecules have been described in recent years: LFA antigens
(CDI1/CD18) mediate leucocyte adherence responses
(Pattarroyo et al., 1987; Suomalainen et al., 1986; Kishimoto
et al., 1987); CD2 antigen expressed by thymocytes binds to
its natural ligand LFA-3 expressed on thymic epithelial cells
(Singer et al., 1987).
Recently, Sanders et al. (1988) convincingly demonstrated
that the adherence of peripheral blood T-lymphocytes and a
T-cell clone (8.2) to the HD cell line L428 was mediated via
two distinct molecular adhesion systems: LFA-3/CD2 and
LFA-I/ICAM-1, with the former system playing the more
dominant role. Thus, our observations that B-cells form only
inefficient associations with L428 may be accounted for by
their lack of surface CD2 expression, thus disabling the
major LFA-3/CD2 pathway but leaving the less efficient
LFA-l/ICAM-l system intact, as LFA-1 (CD1la) is
expressed by B-cell subsets and ICAM-1 by L428. However,
this does not explain Why peripheral blood monocytes which
express LFA-1, but like B-cells do not express CD2, are
equally as good as T-cells at binding to the HD cell lines.
There may thus be an alternative system aiding monocyte
adherence to the HD cell lines. It has recently been shown
that CD4 and class II MHC molecules interact to mediate
cell adhesion (Doyle & Strominger, 1987). Peripheral blood
monocytes do express small amounts of surface CD4 and
L428 and L591 similarly express class II molecules on their
surface, albeit variably. It is therefore conceivable that this
adhesion pathway is operating in monocyte-L428/L591 inter-
actions, perhaps in an additive fashion with the LFA-1/
ICAM-1 system. That the CD4/class II system is operative in
the HD cell line rosette system is supported by our own
observations that T-cell-L428 rosette formation is partially,
though non-significantly, inhibited by antibodies to mono-
morphic determinants of the alpha chain of the HLA DR
molecule. We have not yet investigated this using monocytes
as the rosetting population.
This work was generously supported by a grant from the Cancer
Research Campaign. We are grateful to Dr Eamonn Rooney for
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